2019 annual financial data
TransCode Therapeutics 2019 Operating margin
TransCode Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -456,865 USD and net income was -607,212 USD.
Operating cash flow was -508,508 USD.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -456,865 USD
- Net income
- -607,212 USD
- Operating cash flow
- -508,508 USD